Evidence map›Paper›PMID 28344796›Full record

ArticleUnited European gastroenterology journal2017

Quality of colonoscopy in an emerging country: A prospective, multicentre study in Russia.

Mariya Antipova, Mikhail Burdyukov, Mikhail Bykov, Leonid Domarev, Evgeny Fedorov, Sergey Gabriel, Konstantin Glebov, Sergey Kashin, Mikhail Knyazev, Aleksey Korotkevich and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in United European gastroenterology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. UEG Week 2019 Poster Presentations.United European gastroenterology journal · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 18 institutions in 2 countries.

Mariya AntipovaMariinsky Hospital, St Petersburg, Russia.
Mikhail BurdyukovEuropean Clinic, Moscow, Russia.
Mikhail BykovClinical Regional Hospital after prof. Ochapovsky, Krasnodar, Russia.
Leonid DomarevMunicipal Clinical Hospital n. 50, Moscow, Russia.
Evgeny FedorovMoscow University Hospital n. 31, Moscow, Russia.
Sergey GabrielRegional Clinical Hospital n. 2, Krasnodar, Russia.
Konstantin GlebovMunicipal Clinical Hospital n. 15, n.n. O.M. Filatov, Moscow, Russia.
Sergey KashinYaroslavl Regional Cancer Hospital, Yaroslavl, Russia.
Mikhail KnyazevFederal Medical Enterprise Polyclinic n. 2 of the Ministry of Economic Development, Moscow, Russia.
Aleksey KorotkevichMunicipal Clinical Hospital n. 29, Novokuznetsk, Russia.
Andrey KotovskyMunicipal Clinical Hospital n. 15, n.n. O.M. Filatov, Moscow, Russia.
Irina KruglovaSamara Regional Cancer Center, Samara, Russia.
Vladimir KrushelnitskyRegional Clinical Hospital n. 2, Krasnodar, Russia.
Ekaterina MayatMoscow University Hospital n. 31, Moscow, Russia.
Mikhail MerzlyakovKemerovo Regional Hospital, Kemerovo, Russia.
Dmitry MtvralashviliState Scientific Centre of Coloprovtology, Russia.
Aleksander PyrkhConsultative Diagnostic Center 'Vivea', Khabarovsk, Russia.
Oleg SannikovMedical Care Unit n. 41 of the Federal Biomedical Agency, Glazov, Udmurtia, Russia.
Evgeny ShitikovMunicipal Clinical Hospital n. 50, Moscow, Russia.
Alexander SubbotinHospital n. 13, Nizhny, Novgorod, Russia.
Alexander TaranClinical Regional Hospital after prof. Ochapovsky, Krasnodar, Russia.
Viktor VeselovState Scientific Centre of Coloprovtology, Russia.
Dmitry ZavyalovYaroslavl Regional Cancer Hospital, Yaroslavl, Russia.
Cesare HassanHumanitas Institute, Italy.
Franco RadaelliValduce Hospital, Como, Italy.
Lorenzo RidolaNuovo Regina Margherita Hospital, Rome, Italy.
Alessandro RepiciHumanitas Institute and Humanitas University, Milan, Italy.
Mikhail KorolevMariinsky Hospital, St Petersburg, Russia.
Krasnoyarsk Regional Clinical Hospital · RUCity Clinical Hospital · RUCity Clinical Hospital No15 named. O. M. Filatova · RUGOUZ YaO "Solovyov NV Clinical Emergency Hospital" · RUHumanitas University · ITMoscow City Hospital No 29 · RUState Scientific Center of Coloproctology · RUSt. Petersburg State Health Care Foundation "Mariinsky City Hospital" · RUConsultative and Diagnostic Center · RUEuropean University at Saint Petersburg · RUFederal Medical-Biological Agency · RUKemerovo Cardiology Center · RUMinistry of Economic Development · ITNizhny Novgorod Regional Clinical Hospital named after Semashko · RUNovokuznetsk State Institute of Advanced Medical Education · RUOspedale Regina Margherita · ITOspedale Valduce · ITSamara Regional Clinical Oncology Center · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe quality of colonoscopy has been related to a higher risk of interval cancer, and this issue has been addressed extensively in developed countries. The aim of our study was to explore the main quality indicators of colonoscopy in a large emerging country.

methodsConsecutive patients referred for colonoscopy in 14 centres were prospectively included between July and October 2014. Before colonoscopy, several clinical and demographic variables were collected. Main quality indicators (i.e. caecal intubation rate, (advanced) adenoma detection rate, rate of adequate cleansing and sedation) were collected. Data were analysed at

resultsA total of 8829 (males: 35%; mean age: 57 + 14 years) patients were included, with 11 centres enrolling at least 100 patients. Screening (including non-alarm symptoms) accounted for 59% (5188/8829) of the indications. Sedation and split preparation were used in 26% (2294/8829) and 25% (2187/8829) of the patients. Caecal intubation was achieved in 7616 patients (86%), and it was ≥85% in 8/11 (73%) centres. Adenoma detection rate was 18% (1550/8829), and it was higher than 20% in five (45%) centres, whilst it was lower than 10% in four (33%) centres. At multivariate analysis, age (OR: 1.020, 95% CI: 1.015-1.024), male sex (OR: 1.2, 95% CI: 1.1-1.3), alarm symptoms (OR: 1.8, 95% CI: 1.7-2), split preparation (OR: 1.4, 95% CI: 1.2-1.6), caecal intubation rate (OR: 1.6, 95% CI: 1.3-1.9) and withdrawal time measurement (OR: 1.2, 95% CI: 1.6-2.1) were predictors of a higher adenoma detection rate, while adequate preparation (OR: 3.4: 95% CI: 2.9-3.9) and sedation (OR: 1.3; 95% CI: 1.1-1.6) were the strongest predictors of caecal intubation rate.

conclusionsAccording to our study, there is a substantial intercentre variability in the main quality indicators. Overall, the caecal intubation rate appears to be acceptable in most centres, whilst the overall level of adenoma detection appears low, with less than half of the centres being higher than 20%. Educational and quality assurance programs, including higher rates of sedation and split regimen of preparation, may be necessary to increase the key quality indicators.

Indexed as

adenoma detection ratecaecal intubation ratecolonoscopyQualityscreening

Identifiers

PMID28344796
PMCPMC5349354
OpenAlexW2329583400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.